Method for on-line enrichment detection of antihypertensive drugs based on FASI-MSS
Through the FASI-MSS online dual enrichment technology combined with CE-UV method, the electrophoresis conditions and solvent composition are optimized, and the sensitivity and environmental protection of anti-hypertensive drugs in the existing technology are solved, and efficient detection and environmental protection of mixed drugs are achieved. Testing, suitable for urine sample analysis.
Patent Information
- Application Number
- CN202411250390.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-19
AI Technical Summary
The existing antihypertensive drug detection methods have shortcomings in terms of sensitivity and environmental protection, especially inability to effectively detect mixed drugs, and the consumption of samples and organic solvents is large, which limits its application.
Field amplification injection (FASI) combined with micelle solvent accumulation (MSS) online dual enrichment technology, combined with capillary electrophoresis (CE) and ultraviolet detection (UV), to achieve the conversion of angiotensin by optimizing electrophoresis conditions and solvent composition. High sensitivity isolation and detection of enzyme inhibitor drugs.
Significantly improve the detection sensitivity, reduce the consumption of samples and organic solvents, and can effectively detect captopril, benapril and lisinopril in urine samples, with the enrichment multiples reaching 130, 155 and 250, which meets green Chemical concept, suitable for clinical drug analysis.
Smart Images

Figure CN118980730A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of enrichment detection of antihypertensive drugs, and in particular to a method for online enrichment detection of antihypertensive drugs based on FASI-MSS. Background Art
[0002] Angiotensin-converting enzyme inhibitors (ACEI) have a antihypertensive effect, can delay and reverse ventricular remodeling, prevent the further development of myocardial hypertrophy, improve vascular endothelial function and cardiac function, reduce the occurrence of arrhythmias, and also increase survival rate and improve prognosis.
[0003] Captopril, benazepril and lisinopril are all antihypertensive drugs belonging to the angiotensin-converting enzyme inhibitor class. They exert their therapeutic effects by preventing the conversion of angiotensin I to angiotensin II and reducing the production of angiotensin II.
[0004] At present, there are many literature reports on the detection of angiotensin converting enzyme inhibitor antihypertensive drugs. Commonly used detection methods include high performance liquid chromatography (HPLC) separation technology combined with ultraviolet (UV) detection, electrochemical methods, capillary electrophoresis (CE), etc. Among these detection methods, the HPLC-based method has high analytical sensitivity and good performance, but the consumption of samples and organic solvents is large during use, which does not conform to the concept of green chemistry. The detection sensitivity of the electrochemical method is also high, but it cannot be used for the separation and detection of mixed drugs. The capillary has a short optical path and a small sample injection volume. When used in conjunction with UV and DAD (diode array) detectors, it will result in relatively low detection sensitivity, which is a disadvantage in actual sample detection and limits the application of CE in trace analysis.
[0005] Therefore, it is particularly important to develop a method that is not only in line with the concept of green chemistry but also has high sensitivity and can be used for the separation and detection of mixed antihypertensive drugs. Summary of the invention
[0006] In view of this, the object of the present invention is to provide a method for online enrichment and detection of antihypertensive drugs based on FASI-MSS, which not only conforms to the concept of green chemistry, but also has high sensitivity and can be used for the separation and detection of mixed antihypertensive drugs.
[0007] In order to achieve the above object, the present invention provides the following technical solutions:
[0008] In a first aspect, a method for online enrichment detection of antihypertensive drugs based on FASI-MSS is provided, the method comprising the following steps:
[0009] S1. Target analyte sample preparation:
[0010] A blank urine sample is placed in a centrifuge tube, a mixed standard solution of captopril, benazepril and lisinopril is added, ethyl acetate is added for extraction, the upper ethyl acetate layer is taken out after centrifugation, dried by air flow, and finally dissolved in water to obtain a target analyte sample;
[0011] S2. Capillary column pretreatment:
[0012] Before using a new capillary column, rinse it with ultrapure water and then treat it with NaOH overnight;
[0013] Before the first injection, the capillary column was flushed with ultrapure water and 1 mol / L NaOH at a pressure of 20 psi, then with ultrapure water, then with HDMB solution, then with ultrapure water, and finally with BGE;
[0014] S3. Sample enrichment of target analytes:
[0015] First, the micelle solution was injected at a pressure of 0.5 psi for 60 s;
[0016] Then, injecting a first amount of the target analyte sample under the conditions of a pressure of 0.5 psi and a time of 5 s;
[0017] Finally, a second amount of the target analyte sample was electrokinetically injected under the conditions of -10 kV and 90 s;
[0018] S4. Target analyte sample detection:
[0019] The separation and detection of the target analyte samples were carried out under the conditions of separation voltage of -20 kV, capillary column temperature of 25°C and detection wavelength of 214 nm.
[0020] Preferably, the first amount can be calculated according to the formula Calculate, where r is the inner radius of the capillary, ΔP is the pressure difference across the capillary cross section, c is the target analyte sample concentration, η is the viscosity of the BGE, L is the capillary length, and t is the migration time of the target analyte sample.
[0021] The second quantity can be calculated according to the formula Calculate, where r is the inner radius of the capillary, E inj is the injection voltage, t inj is the injection time, E sep is the separation voltage, L is the capillary length, and t is the migration time of the target analyte sample.
[0022] Preferably, the method further comprises the following steps:
[0023] To flush the capillary column:
[0024] Between two injections, the capillary column was flushed with ultrapure water for 3 min, HDMB solution for 3 min, ultrapure water for 3 min, and BGE for 3 min at a pressure of 20 psi.
[0025] Preferably, the BGE is a 75 mmol / L NH4HCO3 solution containing 40% methanol by volume, and the pH value of the BGE is adjusted by HCl and NaOH.
[0026] Preferably, the micellar solution contains [C 14 MIm]Br in NH4HCO3 solution.
[0027] More preferably, the micellar solution contains 8 mmol / L [C 14 MIm]Br 25mmol / L NH4HCO3 solution.
[0028] In the present invention, HDMB means hexadimethoxine bromide, and BGE means background electrolyte.
[0029] Preferably, the antihypertensive drug is an angiotensin converting enzyme inhibitor, and the angiotensin converting enzyme inhibitor includes captopril, benazepril and lisinopril.
[0030] Preferably, the enrichment factor of captopril is 130, the enrichment factor of benazepril is 155, and the enrichment factor of lisinopril is 250.
[0031] In a second aspect, there is provided application of the method described in the present invention in enrichment detection of antihypertensive drugs.
[0032] In a third aspect, the invention provides application of the method described in the present invention in enrichment and detection of angiotensin converting enzyme inhibitors.
[0033] In a fourth aspect, there is provided application of the method described in the present invention in enrichment and detection of captopril, benazepril and / or lisinopril.
[0034] Compared with the prior art, the beneficial effects of the present invention are:
[0035] The present invention establishes an online double enrichment method combining field amplified sample injection (FASI) with micellar solvent stacking (MSS) for separation and detection of three angiotensin converting enzyme inhibitors (captopril, benazepril, lisinopril) by capillary electrophoresis. The enrichment factor of captopril in the method of the present invention is 130, and the detection limit of captopril is 13.9 ng·mL -1 The limit of quantification for captopril was 30 ng·mL -1 ; The enrichment factor for benazepril is 155, and the detection limit for benazepril is 4.8 ng·mL -1The limit of quantification for benazepril was 7.5 ng·mL -1 ; The enrichment factor of lisinopril is 250, and the detection limit of lisinopril is 16.1 ng·mL -1 The limit of quantification for lisinopril was 30 ng·mL -1 .
[0036] The method of the present invention uses FASI-MSS online double enrichment technology in CE-UV method, separates and detects three angiotensin converting enzyme inhibitors (captopril, benazepril, lisinopril) antihypertensive drugs, and examines the factors affecting online enrichment, separation and detection in detail. Compared with the conventional sampling method, the enrichment multiples reach 133, 155 and 250 respectively, which significantly improves the sensitivity of detection. At the same time, the method has the advantages of simplicity, high sensitivity and rapidity, and can also be used for the analysis of actual samples, which provides a possible new method for clinical drug analysis.
[0037] The method of the present invention can be successfully applied to the enrichment detection of captopril, benazepril and lisinopril in urine samples, with a recovery rate in the range of 88.7%-110.4%, and the intra-day and inter-day reproducibility of migration time and peak area are lower than 6.0% (RSDs, n=5), which verifies the applicability and feasibility of the method of the present invention.
[0038] In addition, the method for online enrichment and detection of antihypertensive drugs based on FASI-MSS of the present invention consumes very little sample and organic solvent during use, which is in line with the concept of green chemistry. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 The electrophoretic diagrams of the standard solution of conventional CE separation (A) and the embodiment of the present invention based on FASI-MSS online double enrichment technology (B); the abscissa represents time, and the ordinate represents UV absorption value; the conventional CE separation conditions are: 0.5psi×8s; the FASI-MSS conditions are: BGE is 75mM NH4HCO3+40% methanol, and the micellar solution is 8mM [C 14 MIm]Br+25mM NH4HCO3, injection conditions: micelle 0.5pai×60s, sample 0.5psi×5s, -10kv×90s, sample matrix is 30% methanol, detection wavelength is 214nm, temperature is 25℃.
[0040] Figure 2 Blank urine sample (a) and 0.5 μg mL -1 Captopril, 0.125 μg mL -1 Benazepril, 0.5 μg mL -1(b) Electrophoresis of lisinopril-spiked urine sample. The horizontal axis represents time and the vertical axis represents UV absorption value.
[0041] In the figure, the substance represented by 1 is captopril, the substance represented by 2 is benazepril, and the substance represented by 3 is lisinopril. DETAILED DESCRIPTION
[0042] The technical solution of the present invention is clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0043] Example 1 Experimental part
[0044] 1.1 Instruments and reagents
[0045] Instruments: Beckman P / ACE MDQ capillary electrophoresis instrument (Beckman, USA, UV), capillary column (Yongnian Ruifeng Chromatographic Devices Co., Ltd.). Data acquisition and processing were completed by 32Karat Software Version 8.0. PB-10 digital acidity meter (Sartorius Scientific Instrument Co., Ltd.), centrifuge (Hunan Xiangyi Instrument Development Co., Ltd.).
[0046] Drugs: Captopril, lisinopril, benazepril, methanol, [C 14 MIm]Br, NH4HCO3, ethyl acetate, NaOH, hexadimethoxine bromide (HDMB).
[0047] Preparation of mixed standard solution: Dissolve captopril, benazepril and lisinopril in ultrapure water to a concentration of 1 mg mL -1 The mixed standard solution was stored in a refrigerator at 4°C away from light. The background electrolyte (BGE) was a NH4HCO3 solution containing 40% (V:V) methanol, and the pH was adjusted by HCl and NaOH. The micellar solution was prepared by mixing [C 14 MIm]Br is obtained by dissolving in NH4HCO3 solution. Ultrapure water is used to prepare a 1% HDMB solution. The prepared solution is filtered through a 0.22 μm filter membrane before use and then used on the machine.
[0048] 1.2 Electrophoresis conditions
[0049] Electrophoresis conditions:
[0050] Before use, a new capillary column needs to be rinsed with ultrapure water (5 min) and treated with 1 mol / L NaOH overnight.
[0051] At the beginning of each day (before the first injection), the capillary column was flushed in sequence with ultrapure water (5 min), 1 mol / L NaOH (30 min), ultrapure water (5 min), HDMB solution (60 min), ultrapure water (10 min), and BGE (12 min) at a pressure of 20 psi.
[0052] Between two injections, the capillary column was flushed with ultrapure water (3 min), HDMB solution (3 min), ultrapure water (3 min), and BGE (3 min) in sequence at a pressure of 20 psi.
[0053] Injection conditions:
[0054] First, the micellar solution was injected under pressure (0.5 psi, 60 s); then the first amount of sample solution (target analyte sample) was injected (0.5 psi, 5 s); finally, the second amount of target analyte sample was injected electrically (-10 kV, 90 s); the separation voltage was -20 kV, the capillary column temperature was 25 °C, and the detection wavelength was 214 nm. The sample injection conditions for conventional CE separation method are 0.5 psi × 8 s.
[0055] The first quantity can be calculated according to the formula Calculate, where r is the inner radius of the capillary, ΔP is the pressure difference across the capillary cross section, c is the target analyte sample concentration, η is the viscosity of the BGE, L is the capillary length, and t is the migration time of the target analyte sample.
[0056] The second quantity can be calculated according to the formula Calculate, where r is the inner radius of the capillary, E inj is the injection voltage, t inj is the injection time, E sep is the separation voltage, L is the capillary length, and t is the migration time of the target analyte sample.
[0057] 1.3 Urine sample processing (sample preparation for target analytes)
[0058] Take 400 μL of blank urine sample in a 5 mL centrifuge tube, add 100 μL of mixed standard solution of captopril, benazepril and lisinopril, add 2.5 mL of ethyl acetate for extraction, centrifuge at 8000 rpm for 5 min, take out the upper ethyl acetate layer, blow dry with air flow, and finally dissolve with 500 μL of water.
[0059] Example 2 Results and Discussion
[0060] 2.1 Optimization of CE separation conditions
[0061] 2.1.1 Optimization of background electrolyte pH
[0062] In this experiment, NH4HCO3 was selected as BGE, and its effect on separation under the condition of pH range 7-8.5 was investigated. When the pH was less than 7.5, the separation effect of benazepril and lisinopril was poor. As the pH value of BGE increased, the separation degree gradually increased. However, when the pH was 8.0, the peak intensity decreased, and the migration time was longer. Considering comprehensively that when the pH value of BGE was 7.5, the separation degree was higher, the peak shape was better, and the peak response was larger, pH = 7.5 was selected for the next step of research.
[0063] 2.1.2 Optimization of background electrolyte concentration
[0064] This experiment investigated the effect of NH4HCO3 concentration (50mM-120mmol / L) on separation and enrichment. As the concentration of BGE increased, the electroosmotic flow gradually decreased, the migration time of each component became longer, and the separation increased. However, when the concentration is too high, the Joule heating effect will occur due to the high ion strength, resulting in poor stacking efficiency. Based on the separation, peak shape and signal intensity, the NH4HCO3 concentration was finally determined to be 75mmol / L.
[0065] 2.1.3 Optimization of methanol ratio in BGE
[0066] The content of organic solvent in BGE is an important parameter affecting the MSS enrichment effect of analytes. The increase of organic solvent content can reduce the conductivity of BGE and weaken the interaction between analytes and micelles, which is beneficial to MSS enrichment. When other conditions remain unchanged, the addition ratio of methanol (20%-50%; V:V) is optimized to obtain better separation and enrichment effects. With the increase of methanol content, the separation degree of the three drugs gradually increases, and at the same time, the migration time is prolonged. At 40%, the peak intensity is the highest, the peak shape is better, and the separation degree is also higher. Therefore, the methanol ratio in BGE is determined to be 40%.
[0067] 2.1.4 Micellar solution [C 14 Optimization of MIm]Br concentration
[0068] In this experiment, different concentrations of [C 14 MIm]Br (4-16mM) was investigated. 14 The concentration of MIm]Br should be higher than CMC (critical micelle concentration) to form micelles. 14 If the concentration of [MIm]Br) is too high, the affinity between the analyte and the micelle will be too strong, and the analyte cannot be released, which will lead to the failure of MSS enrichment. 14 The CMC of MIm]Br is 2.8mM, so the experiment was conducted on different concentrations of [C 14 MIm]Br (4-16mM) was investigated.14 When the MIm]Br concentration was 4 mM, the concentration was too low, resulting in poor MSS enrichment effect, so the peak intensity of the sample was low. 14 When the concentration of MIm]Br increased from 8mM to 16mM, the migration time of the sample gradually increased, the peak intensity decreased, and tailing occurred. 14 The concentration of MIm]Br was 8 mM.
[0069] 2.1.5 Optimization of sample injection time
[0070] Before electric injection, the target analyte sample was injected for 5 seconds under a pressure of 0.5psi, which can help improve the enrichment effect and reproducibility. The injection conditions of the fixed micelle solution were 0.5psi×60s. When the injection high voltage was -10kV, the injection time (60s, 75s, 90s, 105s, 120s) of the sample (target analyte sample) was investigated. As the injection time increased, the injection volume increased, and the peak area of each analyte gradually increased. When the injection time exceeded 90s, the injection volume was too large, resulting in the micelle solution being unable to capture the sample ions, the sample response decreased, and the separation degree also decreased. Therefore, 90s was selected as the sample injection time.
[0071] 2.1.6 Optimization of micelle injection time
[0072] The injection pressure of the micellar solution was 0.5 psi, and the injection time was 30s, 45s, 60s, 75s and 90s, respectively. As the injection time of the micellar solution increased, the peak areas of captopril, benazepril and lisinopril first increased and then decreased, reaching the maximum at 60s; when the injection time of the micellar solution was too long, the excess micelles caused the analyte peak to broaden and the separation degree to decrease. Therefore, the injection time of the micellar solution was finally determined to be 60s.
[0073] 2.1.7 Optimization of methanol ratio in sample matrix
[0074] This experiment investigated different proportions of methanol (10-40%) in the sample matrix. As the proportion of methanol gradually increased, the peak areas of the three analytes gradually increased. When the concentration exceeded 30%, the analyte peak areas decreased and the separation became smaller. Therefore, 30% methanol was selected as the sample matrix in this experiment.
[0075] The optimal experimental conditions are as follows: 75mmol / L NH4HCO3 containing 40% methanol as BGE; 8mmol / L [C 14The 25mmol / L NH4HCO3 of MIm]Br was used as the micellar solution and injected at 0.5psi for 60s. The sample matrix was 30% methanol and injected at 0.5psi for 5s and then injected electrokinetically at -10kV for 90s. The analytical performance of the method was evaluated using a mixed standard solution under the above conditions.
[0076] 2.2 Analysis of sample enrichment results
[0077] Under the optimal experimental conditions, three antihypertensive drugs were separated and detected based on FASI-MSS online double enrichment technology. Figure 1 The electrophoretic diagrams are obtained by conventional sample injection and the FASI-MSS online double enrichment technology according to the embodiment of the present invention. Figure 1 The concentrations of captopril, benazepril, and lisinopril in A are 40 μg mL -1 , 10μg·mL -1 , 40 μg·mL -1 , Figure 1 The concentrations of captopril, benazepril, and lisinopril in B were 2 μg mL -1 , 0.5 μg·mL -1 , 2μg·mL -1 It can be seen that after the FASI-MSS online double enrichment technology in the embodiment of the present invention, the peak response values of the three drugs (captopril, benazepril and lisinopril) are significantly improved. The enrichment factors (SEF) of the three drugs are calculated according to the following formula: 130, 155, and 250, respectively.
[0078]
[0079] 2.3 Linear range, reproducibility and detection limit of the method
[0080] The method was verified under the optimal experimental conditions, and the calibration curves obtained by plotting the peak area against the corresponding analyte concentration showed a good linear relationship. The detection limits of the three drugs were 13.9 ng·mL -1 , 4.8ng·mL -1 , 16.1ng·mL -1 , and the limits of quantification were 30 ng·mL -1 , 7.5ng·mL -1 、30ng·mL -1The CE-UV method based on FASI-MSS was compared with other methods for the detection of the three drugs. The sensitivity of this method is higher than that of fluorescence and spectrophotometry, and is roughly equivalent to some HPLC-UV, HPLC-MS and electrochemical methods. Compared with other CE methods such as CE-DAD and MEKC-PDA (micellar electrokinetic chromatography-photodiode array detector), the detection sensitivity of the method of the embodiment of the present invention is higher. 2μg·mL -1 Captopril, 0.5 μg mL -1 Benazepril, 2 μg mL -1 The mixed standard solution of lisinopril was measured 5 times in a day, and the relative standard deviations (RSDs) of the migration time were <1.7%, and the RSDs of the peak area were <4.0%; the measurement was carried out for 5 consecutive days, and the RSDs of the migration time were <2.8%, and the RSDs of the peak area were <4.5%. The results show that the method of the embodiment of the present invention has good reproducibility.
[0081] 2.4 Urine analysis
[0082] The method of the present invention was applied to urine samples spiked with three drugs (0.5 μg mL -1 Captopril, 0.125 μg mL -1 Benazepril, 0.5 μg mL -1 The feasibility of this method was verified by analysis of lisinopril. Figure 2 a in the figure is the electrophoresis diagram of blank urine sample. Figure 2 Figure b is the electrophoresis diagram of the spiked urine sample. It can be observed that the matrix in the urine sample did not interfere with the determination of the three drugs. Five parallel experiments were conducted on the spiked urine samples with three different concentration levels of drugs added, and the average recovery and precision corresponding to each target analyte were calculated. The average recovery of the three drugs was between 88.7% and 110.4%, the RSDs of the migration time were <2.3%, and the RSDs of the peak area were <6.0%. This shows that the implementation method of the present invention can be applied to the analysis of such antihypertensive drugs in urine samples.
[0083] The embodiments described above are only some embodiments of the present invention, not all embodiments. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but only represents selected embodiments of the present invention. All other embodiments obtained without creative work and related deductions and substitutions made by ordinary technicians in the field under the conditions of the concept of the present invention belong to the scope of protection of the present invention.
Claims
1. A method for detecting antihypertensive drugs based on FASI-MSS online enrichment, characterized in that: The method comprises the following steps: S1. Target analyte sample preparation: A blank urine sample is placed in a centrifuge tube, a mixed standard solution of captopril, benazepril and lisinopril is added, ethyl acetate is added for extraction, the upper ethyl acetate layer is taken out after centrifugation, dried by air flow, and finally dissolved in water to obtain a target analyte sample; S2. Capillary column pretreatment: Before using a new capillary column, rinse it with ultrapure water and then treat it with NaOH overnight; Before the first injection, the capillary column was flushed with ultrapure water and 1 mol / L NaOH at a pressure of 20 psi, then with ultrapure water, then with HDMB solution, then with ultrapure water, and finally with BGE; S3. Sample enrichment of target analytes: First, the micelle solution was injected at a pressure of 0.5 psi for 60 s; Then, injecting a first amount of the target analyte sample under the conditions of a pressure of 0.5 psi and a time of 5 s; Finally, a second amount of the target analyte sample was electrokinetically injected under the conditions of -10 kV and 90 s; S4. Target analyte sample detection: The separation and detection of the target analyte samples were carried out under the conditions of separation voltage of -20 kV, capillary column temperature of 25°C and detection wavelength of 214 nm.
2. The method according to claim 1, characterized in that: The following steps are also included: To flush the capillary column: Between two injections, the capillary column was flushed with ultrapure water for 3 min, HDMB solution for 3 min, ultrapure water for 3 min, and BGE for 3 min at a pressure of 20 psi.
3. The method according to claim 1, characterized in that The BGE is a 75mmol / L NH4HCO3 solution containing 40% methanol by volume, and the pH value of the BGE is adjusted by HCl and NaOH.
4. The method according to claim 1, characterized in that: The micellar solution contains [C 14 MIm]Br in NH4HCO3 solution.
5. The method according to claim 4, characterized in that The micellar solution contains 8 mmol / L [C 14 MIm]Br in 25mmol / L NH4HCO3 solution.
6. The method according to claim 1, characterized in that The antihypertensive drug is an angiotensin converting enzyme inhibitor, which includes captopril, benazepril and lisinopril.
7. The method according to claim 6, characterized in that The enrichment factor of the captopril is 130, the enrichment factor of the benazepril is 155, and the enrichment factor of the lisinopril is 250.
8. Use of the method according to claim 1 in enrichment detection of antihypertensive drugs.
9. Use of the method according to claim 1 in enrichment and detection of angiotensin converting enzyme inhibitors.
10. Use of the method according to claim 1 in enrichment and detection of captopril, benazepril and / or lisinopril.
